Postpartum hemorrhage: Management of massive transfusion

Daneil L. Jackson, Thomas Deloughery

    Research output: Contribution to journalReview article

    Abstract

    In women with postpartum hemorrhage, the need to transfuse a large amount of blood products is frequent. The ABCD of massive transfusions - Assessment/Activation, Blood products, Complications, and Drugs - can help manage this complex situation. There needs to be a defined method to activate the massive transfusion protocol and a well-defined means to assess the coagulation status of the patient by either traditional laboratory tests or point of care methods such as thromboelastography. Recent data supports more aggressive use of plasma in the massively transfused patient. Obstetricians need to be vigilant in assessing compilations, especially hypothermia. Given the increased use of antithrombotic drugs in bleeding patients, one needs to consider reversal of these agents. Finally, consideration of the role of other agents such as antifibrinolytic agents in the management of the bleeding patient is important. It is important for every hospital to have a well-defined massive transfusion protocol to streamline the care of postpartum hemorrhage. Target Audience Obstetricians and gynecologists, family physicians. Learning Objectives After completing this activity, the learner should be better able to have a systematic approach to massive transfusions in postpartum hemorrhage, describe recent clinical trials on more aggressive use of plasma and tranexamic acid, and effectively monitor coagulation and for complications of massive transfusion.

    Original languageEnglish (US)
    Pages (from-to)418-422
    Number of pages5
    JournalObstetrical and Gynecological Survey
    Volume73
    Issue number7
    DOIs
    StatePublished - Jul 1 2018

    Fingerprint

    Postpartum Hemorrhage
    Point-of-Care Systems
    Hemorrhage
    Thrombelastography
    Tranexamic Acid
    Antifibrinolytic Agents
    Family Physicians
    Hypothermia
    Pharmaceutical Preparations
    Clinical Trials
    Learning

    ASJC Scopus subject areas

    • Obstetrics and Gynecology

    Cite this

    Postpartum hemorrhage : Management of massive transfusion. / Jackson, Daneil L.; Deloughery, Thomas.

    In: Obstetrical and Gynecological Survey, Vol. 73, No. 7, 01.07.2018, p. 418-422.

    Research output: Contribution to journalReview article

    @article{f0d1c4cd1bd145b29ec4ce37f0e1d41e,
    title = "Postpartum hemorrhage: Management of massive transfusion",
    abstract = "In women with postpartum hemorrhage, the need to transfuse a large amount of blood products is frequent. The ABCD of massive transfusions - Assessment/Activation, Blood products, Complications, and Drugs - can help manage this complex situation. There needs to be a defined method to activate the massive transfusion protocol and a well-defined means to assess the coagulation status of the patient by either traditional laboratory tests or point of care methods such as thromboelastography. Recent data supports more aggressive use of plasma in the massively transfused patient. Obstetricians need to be vigilant in assessing compilations, especially hypothermia. Given the increased use of antithrombotic drugs in bleeding patients, one needs to consider reversal of these agents. Finally, consideration of the role of other agents such as antifibrinolytic agents in the management of the bleeding patient is important. It is important for every hospital to have a well-defined massive transfusion protocol to streamline the care of postpartum hemorrhage. Target Audience Obstetricians and gynecologists, family physicians. Learning Objectives After completing this activity, the learner should be better able to have a systematic approach to massive transfusions in postpartum hemorrhage, describe recent clinical trials on more aggressive use of plasma and tranexamic acid, and effectively monitor coagulation and for complications of massive transfusion.",
    author = "Jackson, {Daneil L.} and Thomas Deloughery",
    year = "2018",
    month = "7",
    day = "1",
    doi = "10.1097/OGX.0000000000000582",
    language = "English (US)",
    volume = "73",
    pages = "418--422",
    journal = "Obstetrical and Gynecological Survey",
    issn = "0029-7828",
    publisher = "Lippincott Williams and Wilkins",
    number = "7",

    }

    TY - JOUR

    T1 - Postpartum hemorrhage

    T2 - Management of massive transfusion

    AU - Jackson, Daneil L.

    AU - Deloughery, Thomas

    PY - 2018/7/1

    Y1 - 2018/7/1

    N2 - In women with postpartum hemorrhage, the need to transfuse a large amount of blood products is frequent. The ABCD of massive transfusions - Assessment/Activation, Blood products, Complications, and Drugs - can help manage this complex situation. There needs to be a defined method to activate the massive transfusion protocol and a well-defined means to assess the coagulation status of the patient by either traditional laboratory tests or point of care methods such as thromboelastography. Recent data supports more aggressive use of plasma in the massively transfused patient. Obstetricians need to be vigilant in assessing compilations, especially hypothermia. Given the increased use of antithrombotic drugs in bleeding patients, one needs to consider reversal of these agents. Finally, consideration of the role of other agents such as antifibrinolytic agents in the management of the bleeding patient is important. It is important for every hospital to have a well-defined massive transfusion protocol to streamline the care of postpartum hemorrhage. Target Audience Obstetricians and gynecologists, family physicians. Learning Objectives After completing this activity, the learner should be better able to have a systematic approach to massive transfusions in postpartum hemorrhage, describe recent clinical trials on more aggressive use of plasma and tranexamic acid, and effectively monitor coagulation and for complications of massive transfusion.

    AB - In women with postpartum hemorrhage, the need to transfuse a large amount of blood products is frequent. The ABCD of massive transfusions - Assessment/Activation, Blood products, Complications, and Drugs - can help manage this complex situation. There needs to be a defined method to activate the massive transfusion protocol and a well-defined means to assess the coagulation status of the patient by either traditional laboratory tests or point of care methods such as thromboelastography. Recent data supports more aggressive use of plasma in the massively transfused patient. Obstetricians need to be vigilant in assessing compilations, especially hypothermia. Given the increased use of antithrombotic drugs in bleeding patients, one needs to consider reversal of these agents. Finally, consideration of the role of other agents such as antifibrinolytic agents in the management of the bleeding patient is important. It is important for every hospital to have a well-defined massive transfusion protocol to streamline the care of postpartum hemorrhage. Target Audience Obstetricians and gynecologists, family physicians. Learning Objectives After completing this activity, the learner should be better able to have a systematic approach to massive transfusions in postpartum hemorrhage, describe recent clinical trials on more aggressive use of plasma and tranexamic acid, and effectively monitor coagulation and for complications of massive transfusion.

    UR - http://www.scopus.com/inward/record.url?scp=85050882331&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=85050882331&partnerID=8YFLogxK

    U2 - 10.1097/OGX.0000000000000582

    DO - 10.1097/OGX.0000000000000582

    M3 - Review article

    C2 - 30062383

    AN - SCOPUS:85050882331

    VL - 73

    SP - 418

    EP - 422

    JO - Obstetrical and Gynecological Survey

    JF - Obstetrical and Gynecological Survey

    SN - 0029-7828

    IS - 7

    ER -